Terra Magnum Capital Partners

ArriVent develops pharmaceutical products to cure presently untreatable cancer.

Walking Fish Therapeutics is developing a platform to harness B cells’ capability to activate the immune system.

Maze Therapeutics is an operator of a biotechnology firm used to focus on translating genetic insights into new medicines.

Structure Therapeutics specializes in the discovery and development of drugs against a type of targets called GPCR.

Senda Biosciences is a therapeutics platform company leveraging unprecedented insights into the molecular connections between humans.

Arcellx is a clinical-stage biotechnology company that provides patients with immune cell therapies.

Flame Biosciences is a clinical-stage company focused on therapies for cancer and other inflammatory diseases.

Erasca is a developer of oncology drugs intended to provide precision oncology options.

Immunocore is a biotechnology company that specializes in the development of TCR bispecific immunotherapies.

Viela Bio is a clinical-stage biotechnology company pioneering and advancing treatments for severe inflammation and autoimmune diseases.